ハギワラ　ノブヒサ   Nobuhisa Hagiwara   萩原　誠久    所属   その他 その他    職種   非常勤嘱託
言語種別	日本語
発表タイトル	Risk Factors for Survival to Hospital Discharge in Patients Treated with Intravenous Amiodarone for the Termination of Ventricular Tachyarrhythmia
会議名	第79回日本循環器学会学術集会
主催者	日本循環器学会
学会区分	全国規模の学会
発表形式	ポスター掲示
講演区分	一般
発表者・共同発表者	◎長柄希実子, 鈴木敦, 後藤雅之, 鈴木豪, 志賀剛, 萩原誠久
発表年月日	2015/04/26
開催地 （都市, 国名）	大阪市
概要	Background: Intravenous amiodarone has been used to terminate and prevent ventricular tachycardia (VT) or fibrillation (VF) including incessant and shock-resistance form. The aim of this study is to evaluate risk factors for survival to hospital discharge after intravenous amiodarone on sustained VT/VF in heart failure (HF) patients. Methods: We examined 38 HF patients with sustained VT/VF or electrical storm (ES) (32 men, age 66±16 years) who were treated with intravenous amiodarone. Results: Amiodarone was effective to terminate sustained VT/VF in 17 of 27 patients, and was effective to inhibit ES in 10 of 11 patients. Baseline C-reactive protein level was an independently associated with survival to hospital discharge (Table). Conclusion: In HF patients with treated with intravenous amiodarone, inflammation may be associated with survival to hospital discharge.